Drug Shortage Report for SOLYSTAT
Report ID | 234061 |
Drug Identification Number | 00755338 |
Brand name | SOLYSTAT |
Common or Proper name | Solystat |
Company Name | PENDOPHARM DIVISION OF PHARMASCIENCE INC |
Market Status | MARKETED |
Active Ingredient(s) | SODIUM POLYSTYRENE SULFONATE |
Strength(s) | 1G |
Dosage form(s) | POWDER FOR SUSPENSION POWDER |
Route of administration | RECTAL ORAL RECTAL ORAL |
Packaging size | 454g |
ATC code | V03AE |
ATC description | ALL OTHER THERAPEUTIC PRODUCTS |
Reason for shortage | Shortage of an active ingredient. |
Anticipated start date | 2024-07-30 |
Actual start date | |
Estimated end date | 2024-10-15 |
Actual end date | 2024-10-15 |
Shortage status | Resolved |
Updated date | 2024-10-16 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 6111 ROYALMOUNT AVE MONTREAL, QUEBEC CANADA H4P 2T4 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v10 | 2024-10-16 | English | Compare |
v9 | 2024-10-15 | French | Compare |
v8 | 2024-10-15 | English | Compare |
v7 | 2024-10-11 | French | Compare |
v6 | 2024-10-11 | English | Compare |
v5 | 2024-09-03 | French | Compare |
v4 | 2024-09-03 | English | Compare |
v3 | 2024-07-31 | English | Compare |
v2 | 2024-07-30 | French | Compare |
v1 | 2024-07-30 | English | Compare |
Showing 1 to 10 of 10